A series of Ce and/or Zr modified WO3-TiO2 catalysts were synthesized by the impregnation method, which were employed for NH3-SCR reaction. The T50 contour lines of NOx were used to quickly optimize catalyst composition, the Ce20Zr12.5WTi catalyst was considered to be the optimization result, and also exhibited excellent NH3-SCR activity and thermal stability with broad operation temperature window, which is a very promising catalyst for NOx abatement from diesel engine exhaust. The excellent catalytic performance is associated with the formation of Ce-Zr solid solution. The introduction of Zr to CeWTi catalyst facilitated the redox of Ce4+/Ce3+ and the formation of more acid sites, more Ce3+ ions, more oxygen vacancies, larger quantities of surface adsorbed oxygen species and NH3, which were beneficial for the excellent selective catalytic reduction (SCR) performance.
Herein, we report the function of copper sites in Cu-SSZ-13, Cu-ZSM-5 and Cu-Beta catalysts with the same Si/Al ratio (14) and Cu/Al ratio (0.4) on selective catalytic reduction of NO with NH3 (NH3-SCR) and reveal the relationship between active sites (Cu sites, acid sites) and catalytic activity. The results show that the amount of isolated Cu2+ ions in the catalysts directly determines the formation of strong Lewis acid sites and reaction intermediate NO3− ions, thus affecting the low-temperature SCR performance, while the amount of highly stable Cu+ ions and Brønsted acid sites is related to the high-temperature SCR performance of the catalysts. Consequently, it contains enough isolated Cu2+ ions, highly stable Cu+ ions and Brønsted acid sites, which endows Cu-SSZ-13 with excellent NH3-SCR activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.